Accessibility Menu
 
Dentsply Sirona logo

Dentsply Sirona

(NASDAQ) XRAY

Current Price$12.07
Market Cap$2.41B
Since IPO (1987)+2,191%
5 Year-79%
1 Year-1%
1 Month-1%

Dentsply Sirona Financials at a Glance

Market Cap

$2.41B

Revenue (TTM)

$3.68B

Net Income (TTM)

$598.00M

EPS (TTM)

$-3.00

P/E Ratio

-4.03

Dividend

$0.48

Beta (Volatility)

0.93 (Low)

Price

$12.07

Volume

61,871

Open

$11.93

Previous Close

$12.07

Daily Range

$11.93 - $12.22

52-Week Range

$9.85 - $17.18

XRAY: Motley Fool Moneyball Superscore

42

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dentsply Sirona

Industry

Healthcare Equipment and Supplies

Employees

14,000

CEO

Daniel T. Scavilla, MBA

Headquarters

Charlotte, NC 28277-3607, US

XRAY Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

7%

Net Income Margin

-16%

Return on Equity

-36%

Return on Capital

6%

Return on Assets

-11%

Earnings Yield

-24.81%

Dividend Yield

0.04%

Payout Ratio

-21.40%

Stock Overview

Market Cap

$2.41B

Shares Outstanding

199.75M

Volume

61.87K

Short Interest

0.00%

Avg. Volume

4.57M

Financials (TTM)

Gross Profit

$1.84B

Operating Income

$252.00M

EBITDA

$46.00M

Operating Cash Flow

$235.00M

Capital Expenditure

$131.00M

Free Cash Flow

$104.00M

Cash & ST Invst.

$326.00M

Total Debt

$2.47B

Dentsply Sirona Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$961.00M

+6.2%

Gross Profit

$443.00M

-0.7%

Gross Margin

46.10%

N/A

Market Cap

$2.41B

N/A

Market Cap/Employee

$172.50K

N/A

Employees

14,000

N/A

Net Income

$146.00M

+66.0%

EBITDA

$32.00M

+92.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.14B

-7.1%

Accounts Receivable

$688.00M

+13.5%

Inventory

$642.00M

+13.8%

Long Term Debt

$2.11B

+25.7%

Short Term Debt

$360.00M

-39.5%

Return on Assets

-11.01%

N/A

Return on Invested Capital

6.17%

N/A

Free Cash Flow

$60.00M

+66.7%

Operating Cash Flow

$101.00M

+16.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LMATLeMaitre Vascular, Inc.
$111.65-2.75%
BHCBausch Health Companies Inc.
$5.82+1.39%
AGIOAgios Pharmaceuticals, Inc.
$34.92+1.36%
HAEHaemonetics Corporation
$60.11-2.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
PBMPsyence Biomedical
$5.87+1.04%
NVDANvidia
$198.43-0.00%
INTCIntel
$68.52+0.06%
TSLATesla
$389.23-0.01%

Questions About XRAY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.